Sarcopenia as the Mobility Phenotype of Aging: Clinical Implications

키워드

참고문헌 (84)

1. Cruz-Jentoft AJ, "Sarcopenia", Lancet, 393, pp.2636~2646 (2019)[DOI]
2. Baumgartner RN, "Epidemiology of sarcopenia among the elderly in New Mexico", Am J Epidemiol, 147, pp.755~763 (1998)[DOI]
3. Janssen I, "Low relative skeletal muscle mass(sarcopenia)in older persons is associated with functional impairment and physical disability", J Am Geriatr Soc, 50, pp.889~896 (2002)[DOI]
4. Cruz-Jentoft AJ, "Sarcopenia : European consensus on definition and diagnosis : Report of the European working group on sarcopenia in older people", Age Ageing, 39, pp.412~423 (2010)[DOI]
5. Studenski SA, "The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates", J Gerontol A Biol Sci Med Sci, 69, pp.547~558 (2014)[DOI]
6. Cruz-Jentoft AJ, "Sarcopenia : revised European consensus on definition and diagnosis", Age Ageing, 48, pp.16~31 (2019)[DOI]
7. Chen LK, "Asian working group for sarcopenia : 2019 consensus update on sarcopenia diagnosis and treatment", J Am Med Dir Assoc, 21, pp.300~307 (2020)[DOI]
8. Chen LK, "Sarcopenia in Asia : consensus report of the Asian working group for sarcopenia", J Am Med Dir Assoc, 15, pp.95~101 (2014)[DOI]
9. Reginster JY, "Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults", Aging Clin Exp Res, 33, pp.3~17 (2021)[DOI]
10. Baek JY, "Korean working group on sarcopenia guideline : expert consensus on sarcopenia screening and diagnosis by the Korean Society of Sarcopenia, the Korean Society for Bone and Mineral Research, and the Korean Geriatrics Society", Ann Geriatr Med Res, 27, pp.9~21 (2023)[DOI]
11. Jung HW, "New clinical practice guidelines for sarcopenia screening and diagnosis in Korean older adults : a step forward", Ann Geriatr Med Res, 27, pp.1~2 (2023)[DOI]
12. Cruz-Jentoft AJ, "Understanding sarcopenia as a geriatric syndrome", Curr Opin Clin Nutr Metab Care, 13, pp.1~7 (2010)[DOI]
13. Bernabei R, "Frailty, physical frailty, sarcopenia : a new conceptual model", Stud Health Technol Inform, 203, pp.78~84 (2014)
14. Cesari M, "Sarcopenia and physical frailty : two sides of the same coin", Front Aging Neurosci, 6, pp.192~ (2014)[DOI]
15. Schaap LA, "Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures : the longitudinal aging study Amsterdam", J Gerontol A Biol Sci Med Sci, 73, pp.1199~1204 (2018)[DOI]
16. Steffl M, "Relationship between sarcopenia and physical activity in older people : a systematic review and meta-analysis", Clin Interv Aging, 12, pp.835~845 (2017)[DOI]
17. Jang IY, "Characteristics of sarcopenia by European consensuses and a phenotype score", J Cachexia Sarcopenia Muscle, 11, pp.497~504 (2020)[DOI]
18. Anker SD, "Welcome to the ICD-10 code for sarcopenia", J Cachexia Sarcopenia Muscle, 7, pp.512~514 (2016)[DOI]
19. Evans WJ, "Sarcopenia : no consensus, no diagnostic criteria, and no approved indication-How did we get here?", Geroscience, 46, pp.183~190 (2024)[DOI]
20. Baek JY, "Geriatrics fact sheet in Korea 2021", Ann Geriatr Med Res, 25, pp.65~71 (2021)[DOI]
21. Kim M, "Sarcopenia in Korean community-dwelling adults aged 70 years and older : application of screening and diagnostic tools from the Asian working group for sarcopenia 2019 update", J Am Med Dir Assoc, 21, pp.752~758 (2020)[DOI]
22. Kim M, "Prevalence of sarcopenia in community-dwelling older adults using the definition of the European Working Group on Sarcopenia in Older People 2 : findings from the Korean Frailty and Aging Cohort Study", Age Ageing, 48, pp.910~916 (2019)[DOI]
23. Lim S, "Sarcopenic obesity : prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging(KLoSHA)", Diabetes Care, 33, pp.1652~1654 (2010)[DOI]
24. Yigit B, "Association between sarcopenia and cognitive functions in older individuals : a cross-sectional study", Ann Geriatr Med Res, 26, pp.134~139 (2022)[DOI]
25. Bunout D, "Association between sarcopenia and mortality in healthy older people", Australas J Ageing, 30, pp.89~92 (2011)[DOI]
26. Cacciatore S, "Preventing osteoporosis, sarcopenia and obesity to care about quality of life", Ann Geriatr Med Res, 27, pp.87~90 (2023)[DOI]
27. Hossain M, "Sarcopenia and adverse post-surgical outcomes in geriatric patients : a scoping review", J Frailty Aging, 10, pp.63~69 (2021)[DOI]
28. Davis MP, "Sarcopenia associated with chemotherapy and targeted agents for cancer therapy", Ann Palliat Med, 8, pp.86~101 (2019)[DOI]
29. Kim TN, "Sarcopenia : definition, epidemiology, and pathophysiology", J Bone Metab, 20, pp.1~10 (2013)[DOI]
30. Shen Y, "Exercise for sarcopenia in older people : a systematic review and network meta-analysis", J Cachexia Sarcopenia Muscle, 14, pp.1199~1211 (2023)[DOI]
31. Moreira-Pais A, "A neuromuscular perspective of sarcopenia pathogenesis : deciphering the signaling pathways involved", Geroscience, 44, pp.1199~1213 (2022)[DOI]
32. Peter AK, "The costamere bridges sarcomeres to the sarcolemma in striated muscle", Prog Pediatr Cardiol, 31, pp.83~88 (2011)[DOI]
33. Sartori R, "Mechanisms of muscle atrophy and hypertrophy : implications in health and disease", Nat Commun, 12, pp.330~ (2021)[DOI]
34. Phillips SM, "Mixed muscle protein synthesis and breakdown after resistance exercise in humans", Am J Physiol, 273, pp.E99~E107 (1997)[DOI]
35. Gasier HG, "Acute resistance exercise augments integrative myofibrillar protein synthesis", Metabolism, 61, pp.153~156 (2012)[DOI]
36. Kim DY, "Applications of eccentric exercise to improve muscle and mobility function in older adults", Ann Geriatr Med Res, 26, pp.4~15 (2022)[DOI]
37. Ziaaldini MM, "Biochemical pathways of sarcopenia and their modulation by physical exercise : a narrative review", Front Med(Lausanne), 4, pp.167~ (2017)[DOI]
38. Deschenes MR, "Adaptive remodeling of the neuromuscular junction with aging", Cells, 11, pp.1150~ (2022)[DOI]
39. Kortebein P, "Functional impact of 10 days of bed rest in healthy older adults", J Gerontol A Biol Sci Med Sci, 63, pp.1076~1081 (2008)[DOI]
40. Robinson S, "Nutrition and sarcopenia : a review of the evidence and implications for preventive strategies", J Aging Res, 2012, pp.510801~ (2012)[DOI]
41. Norman K, "Malnutrition in older adults-recent advances and remaining challenges", Nutrients, 13, pp.2764~ (2021)[DOI]
42. Yoon MS, "mTOR as a key regulator in maintaining skeletal muscle mass", Front Physiol, 8, pp.788~ (2017)[DOI]
43. Zhao Y, "Advances in the role of leucine-sensing in the regulation of protein synthesis in aging skeletal muscle", Front Cell Dev Biol, 9, pp.646482~ (2021)[DOI]
44. Adams GR, "The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy", J Appl Physiol(1985), 81, pp.2509~2516 (1996)[DOI]
45. Cuthbertson D, "Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle", FASEB J, 19, pp.422~424 (2005)[DOI]
46. Haran PH, "Role and potential mechanisms of anabolic resistance in sarcopenia", J Cachexia Sarcopenia Muscle, 3, pp.157~162 (2012)[DOI]
47. Jung HW, "Protein intake recommendation for Korean older adults to prevent sarcopenia : expert consensus by the Korean geriatric society and the Korean nutrition society", Ann Geriatr Med Res, 22, pp.167~175 (2018)[DOI]
48. Tipton KD, "Assessing the role of muscle protein breakdown in response to nutrition and exercise in humans", Sports Med, 48, pp.53~64 (2018)[DOI]
49. Burd NA, "Anabolic resistance of muscle protein synthesis with aging", Exerc Sport Sci Rev, 41, pp.169~173 (2013)[DOI]
50. Draganidis D, "Low-grade systemic inflammation interferes with anabolic and catabolic characteristics of the aged human skeletal muscle", Oxid Med Cell Longev, 2021, pp.8376915~ (2021)[DOI]
51. Christiansen AR, "Selective androgen receptor modulators : the future of androgen therapy?", Transl Androl Urol, 9, pp.S135~S148 (2020)[DOI]
52. Kim BJ, "Effects of muscles on bone metabolism-with a focus on myokines", Ann Geriatr Med Res, 26, pp.63~71 (2022)[DOI]
53. Sawada S, "The 30-s chair stand test can be a useful tool for screening sarcopenia in elderly Japanese participants", BMC Musculoskelet Disord, 22, pp.639~ (2021)[DOI]
54. Yamada M, "Five-repetition sit-to-stand test : end with the fifth stand or sit?", Geriatr Gerontol Int, 22, pp.362~364 (2022)[DOI]
55. Jung HW, "Screening value of timed up and go test for frailty and low physical performance in Korean older population : the Korean frailty and aging cohort study(KFACS)", Ann Geriatr Med Res, 24, pp.259~266 (2020)[DOI]
56. Rose Berlin Piodena-Aportadera M, "Calf circumference measurement protocols for sarcopenia screening : differences in agreement, convergent validity and diagnostic performance", Ann Geriatr Med Res, 26, pp.215~224 (2022)[DOI]
57. Lim JY, "Prevalence of sarcopenia in pre-frail community dwelling older adult and utility of SARC-F, SARC-CalF and calf circumference in case finding", J Frailty Sarcopenia Falls, 5, pp.53~56 (2020)[DOI]
58. Ji S, "Phenotype validation of the Korean working group on sarcopenia guideline", Arch Gerontol Geriatr, 117, pp.105251~ (2024)[DOI]
59. Lunt E, "The clinical usefulness of muscle mass and strength measures in older people : A systematic review", age Ageing, 50, pp.88~95 (2021)[DOI]
60. Evans WJ, "D(3)-Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass", J Cachexia Sarcopenia Muscle, 10, pp.14~21 (2019)[DOI]
61. Kim M, "Prevalence of muscle weakness based on different diagnostic criteria in community-dwelling older adults : a comparison of grip strength dynamometers", Geriatr Gerontol Int, 17, pp.2089~2095 (2017)[DOI]
62. Roberts HC, "A review of the measurement of grip strength in clinical and epidemiological studies : towards a standardised approach", Age Ageing, 40, pp.423~429 (2011)[DOI]
63. Ji S, "Comparing chair stand test protocols : fifth stand versus fifth sit", Geriatr Gerontol Int, 23, pp.976~978 (2023)[DOI]
64. Guralnik JM, "A short physical performance battery assessing lower extremity function : association with self-reported disability and prediction of mortality and nursing home admission", J Gerontol, 49, pp.M85~M94 (1994)[DOI]
65. Jung HW, "Visualizing domains of comprehensive geriatric assessments to grasp frailty spectrum in older adults with a radar chart", Ann Geriatr Med Res, 24, pp.55~56 (2020)[DOI]
66. Tavassoli N, "Implementation of the WHO integrated care for older people(ICOPE)programme in clinical practice : a prospective study", Lancet Healthy Longev, 3, pp.e394~e404 (2022)[DOI]
67. Wong HJ, "Possible sarcopenia and its association with nutritional status, dietary intakes, physical activity and health-related quality of life among older stroke survivors", Ann Geriatr Med Res, 26, pp.162~174 (2022)[DOI]
68. Oh G, "Long-term effect of a 24-week multicomponent intervention on physical performance and frailty in community-dwelling older adults", Age Ageing, 50, pp.2157~2166 (2021)[DOI]
69. Dent E, "International clinical practice guidelines for sarcopenia(ICFSR) : screening, diagnosis and management", J Nutr Health Aging, 22, pp.1148~1161 (2018)[DOI]
70. Park TS, "Effectiveness of an exercise program for older adults using an augmented reality exercise platform : a pilot study", Ann Geriatr Med Res, 27, pp.73~79 (2023)[DOI]
71. Paulussen KJM, "Anabolic resistance of muscle protein turnover comes in various shapes and sizes", Front Nutr, 8, pp.615849~ (2021)[DOI]
72. Cintineo HP, "Effects of protein supplementation on performance and recovery in resistance and endurance training", Front Nutr, 5, pp.83~ (2018)[DOI]
73. Rogeri PS, "Strategies to prevent sarcopenia in the aging process: role of protein intake and exercise", Nutrients, 14, pp.52~ (2021)[DOI]
74. Ko CH, "Effects of enriched branched-chain amino acid supplementation on sarcopenia", Aging(Albany NY), 12, pp.15091~15103 (2020)[DOI]
75. Oktaviana J, "The effect of β-hydroxy-β-methylbutyrate(HMB)on sarcopenia and functional frailty in older persons : a systematic review", J Nutr Health Aging, 23, pp.145~150 (2019)[DOI]
76. Uchitomi R, "Vitamin D and sarcopenia : Potential of vitamin D supplementation in sarcopenia prevention and treatment", Nutrients, 12, pp.3189~ (2020)[DOI]
77. McPherron AC, "Double muscling in cattle due to mutations in the myostatin gene", Proc Natl Acad Sci U S A, 94, pp.12457~12461 (1997)[DOI]
78. Bogdanovich S, "Functional improvement of dystrophic muscle by myostatin blockade", Nature, 420, pp.418~421 (2002)[DOI]
79. Schuelke M, "Myostatin mutation associated with gross muscle hypertrophy in a child", N Engl J Med, 350, pp.2682~2688 (2004)[DOI]
80. Becker C, "Myostatin antibody(LY2495655)in older weak fallers : a proof-of-concept, randomised, phase 2 trial", Lancet Diabetes Endocrinol, 3, pp.948~957 (2015)[DOI]
81. Narkar VA, "AMPK and PPARdelta agonists are exercise mimetics", Cell, 134, pp.405~415 (2008)[DOI]
82. Mohammed I, "A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan", Front Endocrinol(Lausanne), 12, pp.718942~ (2021)[DOI]
83. Dalton JT, "The selective androgen receptor modulator GTx-024(enobosarm)improves lean body mass and physical function in healthy elderly men and postmenopausal women : results of a double-blind, placebo-controlled phase II trial", J Cachexia Sarcopenia Muscle, 2, pp.153~161 (2011)[DOI]
84. Papanicolaou DA, "A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator(SARM), MK-0773 in female participants with sarcopenia", J Nutr Health Aging, 17, pp.533~543 (2013)[DOI]

관련 논문AI추천